Beacon Pointe Advisors, LLC Bio N Tech Se Transaction History
Beacon Pointe Advisors, LLC
- $8.76 Billion
- Q1 2025
A detailed history of Beacon Pointe Advisors, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 89,516 shares of BNTX stock, worth $10.3 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
89,516
Previous 90,021
0.56%
Holding current value
$10.3 Million
Previous $10.3 Million
20.53%
% of portfolio
0.09%
Previous 0.12%
Shares
9 transactions
Others Institutions Holding BNTX
# of Institutions
334Shares Held
40.2MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$941 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$491 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$467 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$219 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$208 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...